REFR 10-K & 10-Q changes, risk factors and insider trading
Research Frontiers Inc. · Nasdaq · Patent Owners & Lessors · CIK 793524 · All filings on SEC.gov
At a glance
What changed in the latest 10-K
Risk Factors
Largest changes
We do not directly manufacture products using SPD technology. We currently depend upon the activities of our licensees in order to be profitable. Although a variety of products have been sold by our licensees, and because it is up to our licensees to decide when and if they will introduce products using SPD technology, we cannot predict when and if our licensees will generate substantial sales of such products. Our SPD technology is currently licensed tosee in full comparisonover 40numerous companies. Other companies are also evaluating SPD technology for use in various products. In the past, some companies have evaluated our technology without proceeding further. While we expect that our licensees would be primarily responsible for manufacturing and marketing SPD-Smart products and components, we are also engaging in market development activities to support our licensees and build the smart glass industry. We cannot control whether or not our licensees will develop SPD products. Some of our licensees appear to be more active than others, some appear to be better capitalized than others, and some licensees appear to be inactive. There is no guarantee when or if our licensees will successfully produce any commercial product using SPD technology in sufficient quantities to make the Company profitable. During 2025, one of our European licensees supplying an automotive OEM filed for bankruptcy and ceased operations. Although production was transitioned to another licensee, royalty recognition during portions of 2025 was affected. We rely on independent licensees to manufacture and sell products incorporating our technology. The financial distress, insolvency or operational disruption of any significant licensee could delay production, disrupt supply chains, affect the timing of royalty income or require transition to alternative licensees, which may not occur without interruption or additional cost.
As of December 31,see in full comparison2024,2025, the Company had cash and cash equivalents of approximately$2.0$0.7 million, working capital of$2.5$0.8 million and total shareholders’ equity of$2.6$0.9 million. Based on our current operations, we expect to have sufficient working capital formore thanthenextforeseeable future.5Basedyearson current operating levels and assumptions regarding future royalty growth, we believe our existing cash and working capital are sufficient to fund operations for the foreseeable future. However, actual results may differ from these expectations due to factors including licensee performance and financial stability, timing ofoperations.royalty receipts, and macroeconomic conditions.
During 2025, five licensees accounted for 21%, 20%, 20%, 19% and 13%, respectively, of fee income recognized for the year. During 2024, four licensees accounted for 34%, 28%, 11% and 11%, respectively, of fee income recognized for the year.see in full comparisonDuring 2023, four licensees accounted for 39%, 16%, 16% and 13%, respectively, of fee income recognized for the year.The loss of all or a substantial portion of the fee income from any of these customers (or certain other significant customers) could have a material adverse effect on our business, financial condition, and/or results of operations.
Full comparison: every changed paragraph (18)
Source
and Need for Capital.Capital
As
of December 31, 2024,2025, the Company had cash and cash equivalents of approximately $2.0$0.7 million, working capital of $2.5$0.8 million and total
shareholders’ equity of $2.6$0.9 million. Based on our current operations, we expect to have sufficient working capital for more than
the nextforeseeable
future. 5Based yearson current operating levels and assumptions regarding future royalty growth, we believe our existing cash and working capital
are sufficient to fund operations for the foreseeable future. However, actual results may differ from these expectations due to factors
including licensee performance and financial stability, timing of operations.royalty receipts, and macroeconomic conditions.
History
of Operating Losses.Losses
We
may not generate sufficient cash flows to cover our operating expenses.expenses
We
have never declared a cash dividend and do not intend to declare a cash dividend in the foreseeable future.future
We
do not directly manufacture products using SPD technology. We currently depend upon the activities of our licensees and their customers
in order to be profitable.profitable
We
do not directly manufacture products using SPD technology. We currently depend upon the activities of our licensees in order to be profitable.
Although a variety of products have been sold by our licensees, and because it is up to our licensees to decide when and if they will
introduce products using SPD technology, we cannot predict when and if our licensees will generate substantial sales of such products.
Our SPD technology is currently licensed to over 40numerous companies. Other companies are also evaluating SPD technology for use in various
products. In the past, some companies have evaluated our technology without proceeding further. While we expect that our licensees would
be primarily responsible for manufacturing and marketing SPD-Smart products and components, we are also engaging in market development
activities to support our licensees and build the smart glass industry. We cannot control whether or not our licensees will develop SPD
products. Some of our licensees appear to be more active than others, some appear to be better capitalized than others, and some licensees
appear to be inactive. There is no guarantee when or if our licensees will successfully produce any commercial product using SPD technology
in sufficient quantities to make the Company profitable. During 2025, one of our European licensees supplying an automotive OEM filed
for bankruptcy and ceased operations. Although production was transitioned to another licensee, royalty recognition during portions of
2025 was affected. We rely on independent licensees to manufacture and sell products incorporating our technology. The financial distress,
insolvency or operational disruption of any significant licensee could delay production, disrupt supply chains, affect the timing of
royalty income or require transition to alternative licensees, which may not occur without interruption or additional cost.
SPD-Smart
products have only recently been introduced.introduced
We
have several large licensees that account for 10% or more of our annual fee income.income
During
2025, five licensees accounted for 21%, 20%, 20%, 19% and 13%, respectively, of fee income recognized for the year. During 2024, four
licensees accounted for 34%, 28%, 11% and 11%, respectively, of fee income recognized for the year. During 2023, four licensees
accounted for 39%, 16%, 16% and 13%, respectively, of fee income recognized for the year. The loss of all or a substantial
portion of
the fee income from any of these customers (or certain other significant customers) could have a material adverse effect on
our business,
financial condition, and/or results of operations.
SPD-Smart
products face intense competition, which could affect our ability to increase our revenues.revenues
Declining
production of automobiles, airplanes, trains, boats and real estate could harm our business.business
Limited
source of SPD film.film
Our
end-product licensees require a source of SPD film to manufacture finished products. Currently, Showa Denko Chemical and Gauzy Ltd. are
is the only sourcessource of commercial
quantities of SPD-film. There are several other companies that are licensed to manufacture SPD-film, but
they have not begun commercial
production of this film. Our end-product licensees’ ability to sell SPD products could be negatively
impacted if there was a prolonged
disruption in SPD-film availability. Such a disruption could also negatively impact our revenues, results
of operations and financial
condition.
We
are dependent on key personnel.personnel
Dependence
on SPD-Smart technology.technology
Our
patents and other protective measures may not adequately protect our proprietary intellectual property, and we may be infringing on the
rights of others.others
If
we fail to maintain an effective system of internal control over financial reporting, the accuracy and timing of our financial reporting
may be adversely affected.affected
Management's Discussion & Analysis (MD&A)
Largest changes
“Automotive royalty income during 2025 was negatively impacted by the bankruptcy and replacement of a European licensee supplying Ferrari. While underlying Ferrari vehicle sales were strong in 2025, royalty income recognition was reduced due to (i) the cessation of operations by the former licensee and (ii) the application of minimum annual royalty credits under the replacement licensee agreement. Beginning in the third and fourth quarters of 2025, these minimum thresholds were exceeded, allowing additional Ferrari-related royalty income to be recognized.”see in full comparison
The Company’s net investment income for the year ended December 31,see in full comparison20242025 was$95,339$39,227 as compared to net investment income of$124,938$95,339 for the year ended December 31,2023.2024. This difference was primarily due tochanges in interest rates paid on money market accounts and gain on sale of investments of $57,149 during the year ended December 31, 2023, as well aslower cash balances available for investment.
“The investors purchased 1.1 million shares of common stock of the Company at a price of $1.00 per share (which represents the closing market price of the Company’s common stock on February 13, 2026 which was the date that the transaction was agreed to). The Company received $1.1 million in proceeds from the sale of common stock to the investors. …”see in full comparison
Duringsee in full comparison2023,2024, the Company’s cash and cash equivalents balance decreased by$1,754,958$481,772 principally as a result of cash used for operations of $788,819 and for the purchase of property and equipment of $1,623, partially offset by cash generated from theexerciseissuance of capital stock and warrants of$484,502$300,000 as well as cash generated from thesale and maturitiesexercise ofmarketable securitiesoptions of$5,491,535 offset by cash used for operations of $2,295,051 and cash used for the purchase of marketable securities of $5,434,386 and for the purchase of property and equipment of $1,558.$8,670. At December 31,2023,2024, the Company had cash and cash equivalents of$2.5$2.0 million, working capital of$3.3$2.5 million and total shareholders’ equity of$3.5$2.6 million. Based on current operations, we expect to have sufficient working capital for more than the foreseeable future.
Operating expensessee in full comparisondecreasedincreased by$152,237$437,287 for the year ended December 31,20242025 to$2,207,397$2,644,684 from$2,359,634$2,207,397 for the year ended December 31, 2024.2023.Thedecreaseincrease is the result oflowerhigher credit loss expense ($70,000$129,000),lowerhigher directors fees and expenses ($162,000, consisting of non-cash costs of stock options granted to directors), higher marketing and investor relations costs ($59,000), lower patent costs ($45,000$68,000) as well aslowerhigher filmlegalpurchase costs ($40,000) and higher professional fees ($37,000), partially offset by higher foreign taxes withheld on payments received from foreign licensees ($34,000). Operating expenses for the years ended December 31, 2025 and 2024 include $354,000 and2023$84,000,include $84,000 and $137,000,respectively, of non-cash charges for stock options granted toemployeesemployees, directors anddirectors.consultants.
Duringsee in full comparison2024,2025, the Company’s cash and cash equivalents balance decreased by$481,772$1,329,887 principally as a result of cash used for operations of$788,819$1,329,161 and for the purchase of property and equipment of$1,623, partially offset by cash generated from the issuance of capital stock and warrants of $300,000 as well as cash generated from the exercise of options of $8,670.$726. At December 31,2024,2025, the Company had cash and cash equivalents of$2.0$0.7 million, working capital of$2.5$0.9 million and total shareholders’ equity of$2.6$1.0 million. Based on current operations, we expect to have sufficient working capital formoreathanperiod of at least 12 months from thenext five yearsdate ofoperations.this filing.
Full comparison: every changed paragraph (16)
The Company has entered into license agreements covering products using the Company’s SPD technology. When royalties from the sales of licensed products by a licensee exceed its contractual minimum annual royalties, the excess amount is recognized by the Company as fee income in the period that it was earned. Certain of the fees are accrued by, or paid to, the Company in advance of the period in which they are earned, resulting in deferred revenue. Certain license agreements contain minimum annual royalty provisions and prepaid royalty structures. In periods where sales volumes increase rapidly or supply transitions occur, royalty income attributable to such sales may be absorbed by previously paid minimum royalties and not recognized until thresholds are exceeded. As a result, our reported revenues in a particular period may not directly correspond to underlying product sales volumes, which could increase volatility in our reported results.
The
majority of the Company’s fee income comes from the activities of several licensees participating in the automotive market. The
Company currently believes that the automotive market will be the largest source of its royalty income over the next several years. The
Company’s royalty income from this market may be influenced by numerous factors including various trends affecting demand in the
automotive industry and the rate of introduction of new technology in OEM product lines and the impact of COVID-19.lines. In addition to these
macro factors, the Company’s
royalty income from the automotive market could also be influenced by specific factors such as whether
the Company’s SPD-SmartGlass
technology appears as standard equipment or as an option on a particular vehicle, the number of additional
vehicle models that SPD-SmartGlass
appears on, the size of each window on a vehicle and the number of windows on a vehicle that use SPD-SmartGlass,
fluctuations in the
total number of vehicles produced by a manufacturer, and in the percentage of cars within model like produced with
SPD-SmartGlass, and
changes in pricing or exchange rates. Certain license fees, which are paid to the Company in advance of the accounting
period in which
they are earned resulting in the recognition of deferred revenue for the current accounting period, which will be recognized
as fee income
in future periods. Also, licensees offset some or all of their royalty payments on sales of licensed products for a given
period by applying
these advance payments towards such earned royalty payments.
The
Company’s fee income from licensing activities for the year ended December 31, 20242025 was $1,335,531$1,121,248 compared to $909,598$1,335,531 for the
the year ended December 31, 2023.2024. This increasedecrease in fee income in 20242025 by $425,933,$214,283, ana increasedecrease of 47%,16%, was primarily the result of
higher lower royalties
from the automotive and aircraft markets, an increase by 48%, as compared to 2023.markets. The Company expects revenue in
all market segments to increase further as new car models and other
products using the Company’s SPD-SmartGlass technology are
introduced into the market.
Automotive royalty income during 2025 was negatively impacted by the bankruptcy and replacement of a European licensee supplying Ferrari. While underlying Ferrari vehicle sales were strong in 2025, royalty income recognition was reduced due to (i) the cessation of operations by the former licensee and (ii) the application of minimum annual royalty credits under the replacement licensee agreement. Beginning in the third and fourth quarters of 2025, these minimum thresholds were exceeded, allowing additional Ferrari-related royalty income to be recognized.
Operating
expenses decreasedincreased by $152,237$437,287 for the year ended December 31, 20242025 to $2,207,397$2,644,684 from $2,359,634$2,207,397 for the year ended December 31,
2024. 2023.
The decreaseincrease is the result of lowerhigher credit loss expense ($70,000$129,000), lowerhigher directors fees and expenses ($162,000, consisting
of non-cash costs of stock options granted to directors), higher marketing and investor relations costs ($59,000), lower patent
costs ($45,000$68,000) as well as lowerhigher
film legalpurchase costs ($40,000) and higher professional fees ($37,000), partially offset by higher foreign taxes withheld on payments
received from foreign licensees ($34,000). Operating expenses for the years ended December 31, 2025 and
2024 include $354,000 and 2023$84,000, include $84,000 and $137,000,
respectively, of non-cash charges for stock options granted to employeesemployees, directors and directors.
consultants.
Research
and development expenditures decreasedincreased by $13,259$38,725 for the year ended December 31, 20242025 to $570,007$608,732 from $583,266$570,007 for the year ended December
31, 2023.2024. This decreaseincrease was the result of lowerhigher materialsoccupancy costs ($15,000$47,000), as well as higher employee compensation costs ($12,000) partially
offset by lower allocated insurance costs ($14,000) partially offset
by higher allocated facility costs ($17,000$25,000). Research and development costs include non-cash charges for stock options granted to employees
of $5,000$21,000 and $8,000$5,000 in 20242025 and 2023,2024, respectively.
The
Company’s net investment income for the year ended December 31, 20242025 was $95,339$39,227 as compared to net investment income of $124,938$95,339
for the year ended December 31, 2023.2024. This difference was primarily due to changes in interest rates paid on money market accounts and
gain on sale of investments of $57,149 during the year ended December 31, 2023, as well as lower cash balances available for investment.
The
Company recorded $47,357 and $35,152 of other income during the yearyears ended December 31, 20242025 and 2024, respectively, relating to an
Employee Retention Credit, a
refundable payroll tax credit available under the Coronavirus Aid, Relief, and Economic Security Act (“Cares
Act”) that
was designed to keep employees on the payroll during the COVID-19 pandemic.
As
a consequence of the factors discussed above, the Company’s net loss was $1,311,382$2,045,584 ($0.04$0.06 per common share) for the year ended
December 31, 2024,2025, whichas wascompared $596,982, (31%) lower thanto the net loss of $1,908,364$1,311,382 ($0.06$0.04 per common share) for the year ended December
31, 2023.2024.
On February 18, 2026, the Company entered into subscription agreements from a group of private accredited investors, which included family members of a director of the Company, as well as the owner of a licensee of the Company licensed to produce SPD-SmartGlass products including for the retrofit architectural glass market.
The investors purchased 1.1 million shares of common stock of the Company at a price of $1.00 per share (which represents the closing market price of the Company’s common stock on February 13, 2026 which was the date that the transaction was agreed to). The Company received $1.1 million in proceeds from the sale of common stock to the investors. For each share received, the investor also received one warrant (expiring on February 28, 2031) to purchase one share of common stock at an exercise price of $1.10 for warrant exercises occurring on or before February 28, 2027, $1.20 for warrant exercises occurring between March 1, 2027 through February 29, 2028, $1.30 for warrant exercises occurring between March 1, 2028 through February 28, 2029, and $1.50 for warrant exercises occurring after February 28, 2029 and prior to the expiration of the warrants.
The shares were issued to the investors in a private placement and, along with the shares issued in connection with the exercise of any warrants in the future, are not registered and therefore currently subject to at least a six-month holding period by the investor.
During
2024,2025, the Company’s cash and cash equivalents balance decreased by $481,772$1,329,887 principally as a result of cash used for operations
of $788,819$1,329,161 and for the purchase of property and equipment of $1,623, partially offset by cash generated from the issuance of capital
stock and warrants of $300,000 as well as cash generated from the exercise of options of $8,670.$726. At December 31, 2024,2025, the Company had
cash and cash equivalents
of $2.0$0.7 million, working capital of $2.5$0.9 million and total shareholders’ equity of $2.6$1.0 million. Based
on current operations, we
expect to have sufficient working capital for morea thanperiod of at least 12 months from the next five yearsdate of operations.this filing.
The
Company expects to use its cash to fund its research and development of SPD light valves, its expanded marketing initiatives, and for
other working capital purposes. The Company believes that its current cash and cash equivalents would fund its operations for more than
the nextforeseeable five years.future. There can be no assurances that expenditures will not exceed the anticipated amounts or that additional financing,
if required, will be available when needed or, if available, that its terms will be favorable or acceptable to the Company. The eventual
success of the Company and generation of positive cash flow will be dependent upon the extent of commercialization of products using
the Company’s technology by the Company’s licensees and payments of continuing royalties on account thereof.
During
2023,2024, the Company’s cash and cash equivalents balance decreased by $1,754,958$481,772 principally as a result of cash used for operations
of $788,819 and for the purchase of property and equipment of $1,623, partially offset by cash generated from the
exercise issuance of capital
stock and warrants of $484,502$300,000 as well as cash generated from the sale and maturitiesexercise of marketable securitiesoptions of $5,491,535 offset
by cash used for operations of $2,295,051 and cash used for the purchase of marketable securities of $5,434,386 and for the purchase
of property and equipment of $1,558.$8,670. At December 31, 2023,2024, the Company had
cash and cash equivalents of $2.5$2.0 million, working capital
of $3.3$2.5 million and total shareholders’ equity of $3.5$2.6 million. Based
on current operations, we expect to have sufficient working capital for more than the foreseeable future.
Contractual
Obligations:
What changed in the latest 10-Q
Risk Factors
We could not find a separate Risk Factors item in the latest 10-Q. Some companies leave it out of quarterly reports; see the annual 10-K risk factors and the original filing. Open the filing on SEC.gov.
Management's Discussion & Analysis (MD&A)
New heading “Six months ended June 30, 2026 compared to the six months ended June 30, 2025”
Largest changes
“During the six months ended June 30, 2026, the Company’s cash and cash equivalents balance increased by $423,657 as a result of cash received from the sale of common stock and warrants of $1,375,000 partially offset by cash used to fund operations of $951,238 and cash used to purchase fixed assets of $105. As of June 30, 2026, the Company had cash and cash equivalents of approximately $1.1 million, working capital of $1.0 million and total shareholders’ equity of $1.1 million. …”see in full comparison
“Six months ended June 30, 2026 compared to the six months ended June 30, 2025”see in full comparison
“The Company recorded $47,357 of other income for the three months ended March 31, 2025 relating to an Employee Retention Credit, a refundable tax credit available under the CARES Act that was designed to keep employees on the payroll during the Covid-19 pandemic.”see in full comparison
“The Company recorded $47,357 of other income for the six months ended June 30, 2025 relating to an Employee Retention Credit, a refundable tax credit available under the CARES Act that was designed to keep employees on the payroll during the COVID-19 pandemic.”see in full comparison
“The Company’s fee income from licensing activities for the six months ended June 30, 2026 was $222,665 as compared to $689,680 for the six months ended June 30, 2025. This decrease in fee income was primarily the result of royalties and upfront fees recognized by the Company under ASC 606 revenue treatment from a new license agreement entered into in the first six months of 2025, non-recurring royalties from two licensees that ceased operations in the first and second quarter of 2025, and what we believe to be a temporary slow-down due to non-technical issues by our licensee, Gauzy Ltd. …”see in full comparison
The Company’s fee income from licensing activities for the three months endedsee in full comparisonMarchJune31,30, 2026 was$136,319$86,346 as compared to$559,776$129,904 forforthe three months endedMarchJune31,30, 2025. This decrease in fee income was primarily the result of non-recurring royaltiesand upfront fees recognized by the Company under ASC 606 revenue treatmentfrom a licenseenewthatlicenseceasedagreementoperationsenteredafterintothe second quarter of 2025, and what we believe to be a temporary slow-down due to non-technical issues by our licensee, Gauzy Ltd. in thefirst quarterproduction of2025SPD emulsionthatanddidfilmnotandrecur inother business activities, offset by higher royalties relating to thefirstmotorcyclequarterhelmetofand2026.ski/snow goggle market. The Company expects revenue in all market segments to increase as new car models and other products using thetheCompany’s SPD-SmartGlass technology are introduced into the market.
Full comparison: every changed paragraph (19)
The preparation of condensed consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent liabilities at the date of the condensed consolidated financial statements, and reported amounts of revenues and expenses during the reporting periods. Actual results could differ from these estimates.
Three
months ended MarchJune 31,30, 2026 compared to the three months ended MarchJune 31,30, 2025
The
Company’s fee income from licensing activities for the three months ended MarchJune 31,30, 2026 was $136,319$86,346 as compared to $559,776$129,904
for for
the three months ended MarchJune 31,30, 2025. This decrease in fee income was primarily the result of non-recurring royalties and upfront fees recognized
by the Company under ASC 606 revenue treatment from a
licensee newthat licenseceased agreementoperations enteredafter intothe second quarter of 2025, and what we
believe to be a temporary slow-down due to non-technical issues by our licensee, Gauzy Ltd. in the first quarterproduction of 2025SPD
emulsion thatand didfilm notand recur
inother business activities, offset by higher royalties relating to the firstmotorcycle quarterhelmet ofand 2026.ski/snow
goggle market. The Company expects revenue in all market segments to increase as new car models and other products using the
the Company’s SPD-SmartGlass technology are introduced into the market.
Operating
expenses decreased by $115,094 for the three months ended March 31, 2026 to $521,382 from $636,476 for the three months ended March 31,
2025. This decrease is primarily the result of lower directors fees ($120,000).
ResearchOperating
and development expendituresexpenses decreased by $17,527 to $145,350$148,706 for the three months ended MarchJune 31,30, 2026 to $627,216 from $162,877$775,922 for the three months
ended MarchJune 31, 30,
2025. This decrease is primarily athe result of lower allocatedemployee insurance costscompensation ($10,000$111,000) and directors fees and expenses
($107,000), as well as lower allocatedmarketing occupancy
and investor relations ($14,000) and lower insurance costs ($6,000$14,000), partially offset by higher
credit losses ($26,000) as well as higher legal fees ($76,000).
Research and development expenditures decreased by $40,202 to $128,884 for the three months ended June 30, 2026 from $169,086 for the three months ended June 30, 2025. This decrease is primarily a result of lower allocated insurance costs ($14,000), lower employee compensation costs ($9,000), as well as lower allocated occupancy costs ($3,000) and lower other research and development costs ($14,000).
The
Company’s net investment income, consisting of interest income, for the three months ended MarchJune 31,30, 2026 was $5,048$9,586 as compared
to income of $14,533$11,278 for the three months ended MarchJune 31,30, 2025 with the change due to lower cash balances available for investment.
The
Company recorded $47,357 of other income for the three months ended March 31, 2025 relating to an Employee Retention Credit, a refundable
tax credit available under the CARES Act that was designed to keep employees on the payroll during the Covid-19 pandemic.
As
a consequence of the factors discussed above, the Company’s net loss was $525,365$660,168 ($0.02 per common share) for the three months
ended MarchJune 31,30, 2026 as compared to net loss of $177,687$803,826 ($0.01$0.02 per common share) for the three months ended MarchJune 31,30, 2025.
Six months ended June 30, 2026 compared to the six months ended June 30, 2025
The Company’s fee income from licensing activities for the six months ended June 30, 2026 was $222,665 as compared to $689,680 for the six months ended June 30, 2025. This decrease in fee income was primarily the result of royalties and upfront fees recognized by the Company under ASC 606 revenue treatment from a new license agreement entered into in the first six months of 2025, non-recurring royalties from two licensees that ceased operations in the first and second quarter of 2025, and what we believe to be a temporary slow-down due to non-technical issues by our licensee, Gauzy Ltd. in the production of SPD emulsion and film and other business activities, offset by higher royalties relating to the motorcycle helmet and ski/snow goggle market. The Company expects revenue in all market segments to increase as new car models and other products using the Company’s SPD-SmartGlass technology are introduced into the market.
Operating expenses decreased by $263,800 for the six months ended June 30, 2026 to $1,148,598 from $1,412,398 for the six months ended June 30, 2025. This decrease is the result of lower directors’ fees and expenses ($227,000) and lower employee compensation ($138,000), partially offset by higher legal fees ($95,000) and higher credit losses $26,000).
Research and development expenditures decreased by $57,729 to $274,234 for the six months ended June 30, 2026 from $331,963 for the six months ended June 30, 2025. This decrease is primarily a result of lower allocated insurance costs ($24,000), lower employee compensation ($9,000), lower allocated occupancy costs ($9,000), as well as lower other research and development costs ($16,000).
The Company’s net investment income, consisting of interest income, for the six months ended June 30, 2026 was $14,634 as compared to income of $25,811 for the six months ended June 30, 2025 with the change due to lower cash balances available for investment.
The Company recorded $47,357 of other income for the six months ended June 30, 2025 relating to an Employee Retention Credit, a refundable tax credit available under the CARES Act that was designed to keep employees on the payroll during the COVID-19 pandemic.
As a consequence of the factors discussed above, the Company’s net loss was $1,185,533 ($0.03 per common share) for the six months ended June 30, 2026 as compared to net loss of $981,513 ($0.03 per common share) for the six months ended June 30, 2025.
On
February 18, 2026, the Company entered into subscription agreements from a group of privateprivately accredited investors, which included
family family
members of a director of the Company, as well as the owner of a licensee of the Company licensed to produce SPD-SmartGlass
products including
for the retrofit architectural glass market.
During the six months ended June 30, 2026, the Company’s cash and cash equivalents balance increased by $423,657 as a result of cash received from the sale of common stock and warrants of $1,375,000 partially offset by cash used to fund operations of $951,238 and cash used to purchase fixed assets of $105. As of June 30, 2026, the Company had cash and cash equivalents of approximately $1.1 million, working capital of $1.0 million and total shareholders’ equity of $1.1 million. Based upon the Company’s current working capital, recurring losses and negative cash flow from operations, if the Company is unable to generate sufficient cash from operating activities, collect amounts owed to it by third parties, or raise additional funds for a period of 12 months from the issuance of these condensed consolidated financial statements, this raises substantial doubt about the Company’s ability to continue as a going concern. To alleviate this substantial doubt, the Company expects to generate sufficient cash flow from operations through increased use of its SPD Technology by existing licensees, through the Company entering into new license agreements, as well as through the collection of amounts owed to it, and, as a result, the Company does not expect that it will need to raise additional capital over the next 12 months. There is no assurance that the Company’s plans will be successful. The accompanying condensed consolidated financial statements have been prepared on the basis that the Company will continue as a going concern and do not include any adjustments that might result from these uncertainties.
During
the three months ended March 31, 2026, the Company’s cash and cash equivalents balance increased by $615,002 as a result of cash
received from the sale of common stock and warrants of $1,375,000 partially offset by used to fund operations of $759,931 and cash used
to purchase fixed assets of $67. As of March 31, 2026, the Company had cash and cash equivalents of approximately $1.3 million, working
capital of $1.7 million and total shareholders’ equity of $1.8 million. Based on current operations, we expect to have sufficient
working capital for a period of at least 12 months from the date of this filing.
REFR insider buying and selling (Form 4)
Since 2026-04-11, insiders reported open-market purchases in 0 Form 4 filings and open-market sales in 0 filings. Totals add up every open-market (code P and S) line in those filings, using the prices reported in the filings. Awards, option exercises, tax withholding and gifts are listed below but not counted.
No Form 4 stock transactions in this period.
Well-known investors holding REFR (13F)
| Investor | Quarter | Shares | Reported value | % of their 13F | Change vs prior quarter |
|---|---|---|---|---|---|
| Renaissance Technologies | 2026-06-30 | 40,789 | $21.2K | 0.0% | Reduced 40% |